Abstract
NAD+ and NADP+ are among the most important coenzymes in biological systems. Aberrations in the regulation of their synthesis and metabolism could have profound effects on living systems because of the central role played by these coenzymes in intermediary metabolism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baccino, F. M.: Heart and liver cloudy swelling by 6-aminonicotinamide (6-AN) in rats. Sperimentale 112, 61–73 (1962).
Branster, M. V., Morton, R. K.: Comparative rates of synthesis of diphosphopyridine nucleotide by normal and tumor tissue from mouse mammary gland: Studies with isolated nuclei. Biochem. J. 63, 640–646 (1956).
Brunnemann, A., Coper, H., Neubert, D.: Biosynthese und Wirkung des 6-Aminonicotin- amid-adenindinucleotids (6-ANAD). Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 246, 437–451 (1964).
Chamberlain, J. G.: Effects of acute vitamin replacement therapy on 6-aminonicotinamide induced cleft palate late in rat pregnancy. Proc. Soc. exp. Biol. (N. Y.) 124, 888–890 (1966).
Coper, H., Netjbert, D.: Effect of 6-amino NAD and other NAD analogues on the formation of NADH ~ P and its transphosphorylation to ATP. Biochim. biophys. Acta (Amst.) 82, 167–170 (1964).
Dietrich, L. S.: Augmentation of 6-aminonicotinamide antagonism of tumor growth by compounds with estrogenic activity. Cancer Res. 24, 61–63 (1964).
Dietrich, L. S., Friedland, I. M.: 6-Aminonicotinamide and 6-aminonicotinic acid metabolism in nucleated and non-nucleated erythrocytes. Arch. Biochem. Biophys. 88, 313–317 (1960).
Dietrich, L. S., Friedland, I. M., Kaplan, L. A.: Pyridine nucleotide metabolism: Mechanism of action of the niacin antagonist 6-aminonicotinamide. J. biol. Chem. 233, 964–968 (1958a).
Dietrich, L. S., Kaplan, L. A., Friedland, I. M., Martin, D. S.: Quantitative biochemical differences between tumor and host tissue. VI. 6-Aminonicotinamide antagonism of DPN- dependent enzymatic systems. Cancer Res. 18, 1272–1280 (1958b).
Dietrich, L. S., Martin, D. S.: Augmentation of 6-aminonicotinamide antagonism of DPN- dependent enzymatic systems by diethylstilbesterol. Cancer Res. 21, 361–364 (1961).
Dietrich, L. S., Mtjniz, O., Farinas, B., Franklin, L.: 6-Aminonicotinamide-14C utilization by the 755 tumor and host liver tissue. Cancer Res. 28, 1652–1654 (1968).
Glock, G. E., Mclean, P.: Levels of oxidized and reduced diphosphopyridine nucleotide and triphosphopyridine nucleotide in tumours. Biochem. J. 65, 413–416 (1957).
Greengard, P., Sigg, E. B., Fratta, I., Zak, S. B.: Prevention and remission by adrenocortical steroids of nicotinamide deficiency disorders and of 6-aminonicotinamide toxicity in rats and dogs. J. Pharmacol, exp. Ther. 154, 624–631 (1966).
Herken, H., Senft, G., Zemisch, B.: Die Einschränkung des tubulären Natrium- und Kaliumtransportes durch Biosynthese 6-Aminonicotinsäureamid enthaltender Nucleotide. Naunyn- Schmiedeberg’s Arch. exp. Path. Pharmak. 249, 54–70 (1964).
Herken, H., Senft, G., Zemisch, B.: Der Einfluß von 6-Aminonicotinsäureamid auf die Verteilung der Natrium- und Kaliumionen zwischen dem extra- und intracellulären Raum in der Leber und der Skelettmuskulatur. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 253, 364–371 (1966).
Herter, F. P., Weissman, S. G., Thompson, H. G., Jr., Hyman, G., Martin, D. S.: Clinical experience with 6-aminonicotinamide. Cancer Res. 21, 31–37 (1961).
Hogeboom, G. H., Schneider, W. C.: Cytochemical studies. VI. The synthesis of diphosphopyridine nucleotide by liver cell nuclei. J. biol. Chem. 197, 611–620 (1952).
Jedeikin, L. A., Weinhotjse, S.: Metabolism of neoplastic tissue. VI. Assay of oxidized and reduced diphosphopyridine nucleotide in normal and neoplastic tissues. J. biol. Chem. 213, 271–280 (1955).
Johnson, W. J., Mccoll, J. D.: 6-Aminonicotinamide — A potent nicotinamide antagonist. Science 122, 834 (1955).
Johnson, W. J., Mccoll, J. D.: Antimetabolite activity of 6-aminonicotinamide. Fed. Proc. 15, 284 (1956).
Kaplan, N. O., Goldin, A., Humphreys, S. R., Ciotti, M. R., Venditti, J. M.: Significance of enzymatically catalyzed exchange reactions in chemotherapy. Science 120, 437–440 (1954).
Martin, D. S., Dietrich, L. S., Ftjgmann, R. A.: Hormonal augmentation of antimetabolite chemotherapy. Proc. Soc. exp. Biol. (N.Y.) 103, 58–60 (1960).
Morton, R. K.: Enzymic synthesis of coenzyme I in relation to chemical control of cell growth. Nature (Lond.) 181, 540–542 (1958).
Pullman, B., Pullman, A.: Comment on the 6-aminonicotinamide antagonism of DPN- dependent enzymatic systems. Cancer Res. 19, 337–338 (1959).
Redetzki, H. M., Alvarez- O’bourke, F.: 6-Aminonicotinamide, a central nervous system depressant. J. Pharmacol, exp. Ther. 187, 173–178 (1962).
Shapiro, D. M., Dietrich, L. S., Shils, M. E.: Quantitative biochemical differences between tumor and host as a basis for cancer chemotherapy. V. Niacin and 6-aminonicotinamide. Cancer Res. 17, 600–604 (1957).
Sund, H.: The pyridine nucleotide coenzymes. In: Singer, T. P. (Ed.): Biological oxidations, pp. 603–639. New York: Interscience 1968.
Woods, M., Burk, D.: Formation of glycolytic inhibitor from 6-aminonicotinamide by ascites tumor cells in vivo and in vitro, and metabolic requirements for formation of this inhibitor. Biochem. Z. 888, 381–392 (1963).
Zatman, L. J., Kaplan, N. O., Colowick, S. P.: Inhibition of spleen diphosphopyridine nucleotidase by nicotinamide, an exchange reaction. J. biol. Chem. 200, 197–212 (1953).
Zatman, L. J., Kaplan, N. O., Colowick, S. P., Ciotti, M. M.: The isolation and properties of the isonicotinic acid hydrazide analogue of diphosphopyridine nucleotide. J. biol. Chem. 209, 467–484 (1954).
Further References
Harris, T., Netjhoff, V.: Biosynthese, Verteilung und Ausscheidung von 3-Acetyl-6-pyridin, einem Metaboliten des 3-Acetylpyridins. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 253, 221–234 (1966).
Herken, H.: Drug-Induced Pathobiotic Effects. In: Proc. 3rd Intern. Pharmacol. Meeting, Vol. 4: Mechanism of Drug Toxicity, pp. 3–21. Oxford-New York: Pergamon Press 1968 a.
Herken, H.: Functional Discorders of the Brain Induced by Synthesis of Nucleotides Containing 3-Acetylpyridine. Z. klin. Chem. klin. Biochem. 6, 357–367 (1968 b).
Herken, H., Neuhoff, V.: Mikroanalytischer Nachweis von Acetylpyridin-adenin-dinucleotid und Acetylpyridin- adenindinucleotid- phosphat im Gehirn. Hoppe-Seylers Z. physiol. Chem. 331, 85–94 (1963).
Herken, H., Timmler, R.: Kinetik der Dihydrofolsäurereduktase aus Rattenleber und -gehirn mit 3-APADPH und H+ als Wasserstoffdonator. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 250, 293–301 (1965).
Neuhoff, V., Köhler, F.: Biochemische Analyse des Stoffwechsels von 3-Acetylpyridin. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 254, 301–326 (1966).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Dietrich, L.S. (1975). Cytotoxic Analogs of Pyridine Nucleotide Coenzymes. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65806-8_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-65806-8_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65808-2
Online ISBN: 978-3-642-65806-8
eBook Packages: Springer Book Archive